Nymox Pharmaceutical
NYMX
#9793
Rank
A$28.85 M
Marketcap
Country
$0.32
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.35 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$10.32 Million, an increase over its 2021 earnings that were of -A$19.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.35 Million-67.58%
2022 -A$10.32 Million-47.71%
2021 -A$19.74 Million6.61%
2020 -A$18.51 Million-10.91%
2019 -A$20.78 Million24.24%
2018 -A$16.73 Million-20.03%
2017 -A$20.91 Million2.71%
2016 -A$20.36 Million-63.86%
2015 -A$56.34 Million674.44%
2014 -A$7.28 Million-6.11%
2013 -A$7.75 Million-35.66%
2012 -A$12.05 Million-20.76%
2011 -A$15.2 Million38.33%
2010 -A$10.99 Million35.59%
2009 -A$8.11 Million11.8%
2008 -A$7.25 Million-12.94%
2007 -A$8.33 Million8.85%
2006 -A$7.65 Million36.5%
2005 -A$5.61 Million-4.4%
2004 -A$5.87 Million-14.58%
2003 -A$6.87 Million
2001 -A$5.04 Million-20.54%
2000 -A$6.34 Million21.72%
1999 -A$5.21 Million-25.56%
1998 -A$7 Million101.3%
1997 -A$3.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$10.71 B-313,751.09%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.97 B-321,386.44%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.75 B-51,603.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$16.04 B-469,813.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.08 B-851,326.28%๐Ÿ‡บ๐Ÿ‡ธ USA